We are monitoring the impact of COVID-19 on Pancreatic Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1203
Share on
Share on

Global Pancreatic Cancer Market Size, Share, Trends, COVID-19 Impact and Growth Analysis Report – Segmented By Cancer Type, Type of Treatment, End-User and Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1203
Pages: 175

Pancreatic Cancer Market Size (2021 to 2026)

The size of the global pancreatic cancer therapeutics market is estimated to be growing at a CAGR of 7.54% from 2021 to 2026. The size of the market is projected to be worth USD 3.73 billion by 2026 from USD 2.59 billion in 2021.

Pancreatic cancer is caused by the uncontrolled growth of cells in the pancreas. This abnormal, unrestrained growth of cells results in the formation of lumps of tissue, widely referred to as tumors. The presence of tumors prevents the normal functioning of the pancreas. Pancreatic cancer is identified as the uncontrolled growth of cells, i.e., malignant cells in the pancreas tissues. The malignant cells lead to tumor formation in the pancreas, which deters the organ's normal functioning.

The occurrence and mortality rate of pancreatic cancer is more in men than in women. SEER estimates that pancreatic cancer accounts for around seven percent of the total cancer deaths in the US annually.

MARKET DRIVERS:

The increasing pervasiveness of pancreatic cancer in developed nations due to the absence of therapeutic procedures for early-stage detection pushes the pancreatic cancer market.

The significant incidence of pancreatic cancer that initiates germline mutations is also expected to accelerate the market's growth rate. The growing demand for targeted therapy is another factor propelling the growth of the pancreatic cancer market. Targeted therapy singles out particular receptors present in the cancer cells and do not affect the body's healthy peripheral cells, unlike the conventional therapeutics' method like chemotherapy. The increasing pervasiveness of pancreatic cancer and increasing demand for targeted therapy drives the pancreatic cancer market.

MARKET RESTRAINTS:

Affordable and efficient technologies for the timely diagnosis of pancreatic cancer are yet to develop fully. Therefore, most pancreatic cancer patients are being diagnosed at an advanced level of the disease. In the advanced stage of pancreatic cancer, the therapy options are limited, leading to high mortality rates. These factors are restricting the growth of the market for pancreatic cancer therapeutics. Surveys show that only a small percentage (about 12% to 15%) of patients is diagnosed immediately enough to be treated with surgical methods, drugs, and chemotherapy.

Impact of COVID-19 on the global pancreatic cancer market:

The covid-19 pandemic has impacted the global Pancreatic Cancer Treatment Market significantly due to cancer patients being more prone to the coronavirus. Thus, they require more professional care and assistance.

The Coronavirus disease (COVID-19) pandemic is disrupting our health environment. As expected, studies highlighted the great susceptibility of cancer patients to COVID-19 and more severe complications, leading oncologists to rethink patient cancer care deeply.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Type, Treatment Type, End Users, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Eli Lilly, Amgen Inc., Celgene Corp., F. Hoffmann-La Roche, Clovis Oncology Inc., Pfizer, Novartis AG, Threshold Pharmaceuticals Inc., Aduro BioTech Inc., Infinity Pharmaceuticals Inc., and NewLink Genetics Corp.  

 

This research report on the global pancreatic cancer market has been segmented and sub-segmented based on the cancer type, treatment type, end-users, and region.

Pancreatic Cancer Market - By Cancer Type:

  • Exocrine Pancreas Cancer
  • Endocrine Pancreas Cancer

Based on the cancer type, most of the pancreatic cancer patients diagnosed in the world belong to the exocrine class. Therefore, the segment currently governs the market. The endocrine type of cancers, although less common, is still anticipating effective treatment modalities.

The investment in research and development is significant in both types of cancers. However, the growing prevalence and increasing reach of innovative techniques in developing countries are the factors anticipated to drive the exocrine segment's growth during the forecast period.

Pancreatic Cancer Market - By Treatment Type:

  • Surgery
  • Chemotherapy
  • Radiation Therapy
  • Others

Pancreatic Cancer Market - By End User:

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

Based on end-user, the Hospital segment is the significant revenue-generating segment in the global pancreatic cancer therapeutics market, which is supposed to continue in the forecast years.

Pancreatic Cancer Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Globally, North America is the largest market for pancreatic cancer. The prevalence of pancreatic cancer is more in North American countries, with the U.S. having the highest number of pancreatic cancer patients worldwide. North America dominated the pancreatic cancer treatment industry, with the largest revenue share in 2019. It is mainly attributed to the improved healthcare infrastructure, high adoption of pancreatic treatment procedures, and a large target population. Besides, an increasing incidence of pancreatic cancer is aggressively propelling the demand for treatment options.

Europe is expected to be the second-largest market for pancreatic cancer.

Asia-Pacific is anticipated to be the fastest-growing region across the globe. On the other hand, Asia Pacific is expected to witness the fastest growth during the forecast period. The presence of well-established hospitals and critical care centers and a large population suffering from pancreatic cancer would boost the market's development in the Asia Pacific region. Furthermore, with the growing number of pancreatic cancer cases in the Asia Pacific region, the diagnosis and treatment of pancreatic cancer must adhere to the same regimen as in western countries.

KEY MARKET PLAYERS: 

Key companies leading the global pancreatic cancer market profiled in the report are Eli Lilly, Amgen Inc., Celgene Corp., F. Hoffmann-La Roche, Clovis Oncology Inc., Pfizer, Novartis AG, Threshold Pharmaceuticals Inc., Aduro BioTech Inc., Infinity Pharmaceuticals Inc., and NewLink Genetics Corp. 

1. Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Type of Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Surgery    

                                5.1.3 Chemotherapy     

                                5.1.4 Radiation Therapy

                                5.1.5 Others      

                                5.1.6 Y-o-Y Growth Analysis, By Type of Treatment          

                                5.1.7 Market Attractiveness Analysis, By Type of Treatment         

                                5.1.8 Market Share Analysis, By Type of Treatment          

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Exocrine Pancreas Cancer

                                5.2.3 Endocrine Pancreas Cancer              

                                5.2.4 Y-o-Y Growth Analysis, By Type      

                                5.2.5 Market Attractiveness Analysis, By Type     

                                5.2.6 Market Share Analysis, By Type      

                5.3 End-users                   

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Research Institutes             

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End-users            

                                5.3.7 Market Attractiveness Analysis, By End-users          

                                5.3.8 Market Share Analysis, By End-users           

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type of Treatment

                                                6.1.3.3 By Type

                                                6.1.3.4 By End-users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type of Treatment

                                                6.1.4.3 By Type

                                                6.1.4.4 By End-users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type of Treatment

                                                6.1.5.3 By Type

                                                6.1.5.4 By End-users

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 Australia  

                                6.3.6 South Korea           

                6.5 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America         

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Eli Lilly                           

                                8.1.1 Overview

                                8.1.2 Type of Product    

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen, Inc.                

                8.3 Celgene Corp.                           

                8.4 F. Hoffmann-La Roche                           

                8.5 Clovis Oncology Inc.                

                8.6 Pfizer                            

                8.7 Novartis AG                

                8.8 Threshold Pharmaceuticals Inc.                          

                8.9 Aduro BioTech Inc.                  

                8.10 Infinity Pharmaceuticals Inc.                             

                8.11 NewLink Genetics Corp.                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Pancreatic Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  3. Global Surgery Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Radiation Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  8. Global Exocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Endocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  10. Global Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  11. Global Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Research Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  15. North America Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  16. North America Surgery Market, By Region, From 2021 to 2026 (USD Billion)
  17. North America Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  18. North America Radiation Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  19. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  20. North America Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  21. North America Exocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Endocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  23. North America Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  24. North America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  25. North America Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  26. North America Research Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  27. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  28. United States Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  29. United States Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  30. United States Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  31. Canada Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  32. Canada Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  33. Canada Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  34. Europe Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  35. Europe Surgery Market, By Region, From 2021 to 2026 (USD Billion)
  36. Europe Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  37. Europe Radiation Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  38. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  39. Europe Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  40. Europe Exocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  41. Europe Endocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  42. Europe Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  43. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  44. Europe Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  45. Europe Research Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  46. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  47. U.K. Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  48. U.K. Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  49. U.K. Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  50. Germany Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  51. Germany Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  52. Germany Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  53. France Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  54. France Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  55. France Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  56. Italy Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  57. Italy Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  58. Italy Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  59. Spain Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  60. Spain Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  61. Spain Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  62. Asia-Pacific Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  63. Asia-Pacific Surgery Market, By Region, From 2021 to 2026 (USD Billion)
  64. Asia-Pacific Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  65. Asia-Pacific Radiation Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  66. Asia-Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  67. Asia-Pacific Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  68. Asia-Pacific Exocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  69. Asia-Pacific Endocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  70. Asia-Pacific Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  71. Asia-Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  72. Asia-Pacific Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  73. Asia-Pacific Research Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  74. Asia-Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  75. Japan Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  76. Japan Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  77. Japan Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  78. China Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  79. China Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  80. China Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  81. India Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  82. India Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  83. India Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  84. Latin America Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  85. Latin America Surgery Market, By Region, From 2021 to 2026 (USD Billion)
  86. Latin America Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  87. Latin America Radiation Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  88. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  89. Latin America Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  90. Latin America Exocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  91. Latin America Endocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  92. Latin America Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  93. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  94. Latin America Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  95. Latin America Research Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  96. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  97. Brazil Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  98. Brazil Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  99. Brazil Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  100. Rest of Latin America Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  101. Rest of Latin America Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  102. Rest of Latin America Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  103. Middle East & Africa Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  104. Middle East & Africa Surgery Market, By Region, From 2021 to 2026 (USD Billion)
  105. Middle East & Africa Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  106. Middle East & Africa Radiation Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  107. Middle East & Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  108. Middle East & Africa Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  109. Middle East & Africa Exocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  110. Middle East & Africa Endocrine Pancreas Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  111. Middle East & Africa Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  112. Middle East & Africa Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  113. Middle East & Africa Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  114. Middle East & Africa Research Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  115. Middle East & Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  116. Middle East Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  117. Middle East Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  118. Middle East Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)
  119. Africa Pancreatic Cancer Market, By Type of Treatment, From 2021 to 2026 (USD Billion)
  120. Africa Pancreatic Cancer Market, By Type, From 2021 to 2026 (USD Billion)
  121. Africa Pancreatic Cancer Market, By End-users, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample